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Abstract
Background: Dried blood spot (DBS) is a reliable blood collection method for storing samples at room temperature
and easily transporting them. We have previously validated a Real-Time PCR for detection of Streptococcus
pneumoniae in DBS. The objective of this study was to apply this methodology for the diagnosis of S. pneumoniae
and Haemophilus influenzae b (Hib) in DBS samples of children with pneumonia admitted to two hospitals in
Mozambique and Morocco.
Methods: Ply and wzg genes of S. pneumoniae and bexA gene of Hib, were used as targets of Real-Time PCR. 329
DBS samples of children hospitalized with clinical diagnosis of pneumonia were tested.
Results: Real-Time PCR in DBS allowed for a significant increase in microbiological diagnosis of S. pneumoniae and
Hib. When performing blood bacterial culture, only ten isolates of S. pneumoniae and none of Hib were detected
(3·0% positivity rate, IC95% 1·4-5·5%). Real-Time PCR from DBS samples increased the detection yield by 4x fold,
as 30 S. pneumoniae and 11 Hib cases were detected (12·4% positivity rate, IC95% 9·0-16·5%; P<0·001).
Conclusion: Real-Time PCR applied in DBS may be a valuable tool for improving diagnosis and surveillance of
pneumonia caused by S. pneumoniae or Hib in developing countries.
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Introduction
Pneumonia is the main cause of death in children worldwide.
It is estimated that it kills 1·2 million children under five years
every year, accounting for 18% of all deaths in this population
group [1]. Streptococcus pneumoniae and Haemophilus
influenzae b (Hib) are the two principal causes of bacterial
pneumonia [1], and also major causes of other invasive
bacterial diseases. These pathogens can be prevented by
immunization or treated with low cost antibiotics but it has been
estimated that only 30% of children with bacterial pneumonia
receive the antibiotics that they need [2].
The introduction of the Hib conjugate vaccine into national
childhood immunization programs in the 1990s has resulted in
a marked and sustained reduction in the incidence of invasive
Hib disease in many countries [3-5]. Recently, this vaccine has
been introduced in many developing countries through the
Expanded Programs of immunization (EPI), with similar
reported decreases in invasive Hib disease [6]. Similarly, in
2000 a conjugated vaccine against seven pneumococcal
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serotypes started to be implemented and showed to be highly
effective to prevent pneumococcal disease caused by the
serotypes included in the vaccine [7]. Since 2012, WHO
recommends the introduction of two new pneumococcal
conjugate vaccines (against 10 and 13 serotypes) in childhood
immunization programs worldwide, since the additional
serotype coverage represents an important progress against
pneumococcal disease.
In order to monitor trends and detect changes in the
epidemiology of S. pneumoniae and Hib after the introduction
of the vaccines, routine surveillance of episodes caused by
these pathogens is mandatory. While this is feasible in most
developed settings, it is seldom performed in the developing
world. Bacterial culture, traditionally considered the gold
standard methodology for bacterial surveillance, is less
sensitive than molecular methods in the diagnosis of
pneumococcal and Hib invasive disease [8-10]. In the majority
of developing countries, the prevalence of invasive disease
caused by S. pneumoniae and/or Hib is not adequately known
due to the scarcity of available laboratories, microbiological or
molecular diagnostic tools and expertise. This hinders such
countries’ surveillance efforts, and thus their potential
application to international funds to support the introduction of
conjugate vaccines. Moreover, sample preservation prior to
shipment to national/international reference laboratories poses
an additional challenge and may jeopardize the quality of
collected material [11].
Dried blood spot (DBS) is a reliable method of blood
collection used for the diagnosis of several human diseases.
DBS is a particularly useful method for storing samples and
diagnosing pediatric conditions in which often very small
volumes of sample are available, and for the screening of high-
risk populations especially in countries where health care
facilities are not readily accessible [12,13]. We have previously
described that the DBS technique enables reproducible storage
of samples for identification and serotyping of S. pneumoniae
and that its use is an attractive method for preserving samples
at room temperature and easily transporting them [14].
The main objective of the present study was to evaluate the
presence of S pneumoniae and Hib in DBS samples from
pediatric patients with diagnosis of clinical pneumonia in two
distinct epidemiological settings in Africa: Manhiça District
Hospital (MDH), Mozambique; and the Hôpitald’enfants de
Rabat (HER), Morocco. DBS samples of a control group of
healthy children recruited in MDH were also analyzed.
Materials and Methods
Study design and characteristics of patients and
healthy controls included in the study
DBS samples were obtained from children participating in
two prospective studies on the epidemiology of acute
respiratory infections conducted in Mozambique and Morocco.
In Manhiça, Mozambique, children younger than 10 years
admitted to MDH with a clinical diagnosis of pneumonia
according to WHO criteria [15] from February 2010 to June
2012 were recruited. In Rabat, Morocco, recruitment covered
children aged 2 months to 5 years admitted to the HER with the
same clinical diagnosis from January to December 2011. WHO
clinical pneumonia criteria include the presence of an
increased respiratory rate (according to age), cough and/or
difficulty in breathing [15]. These patients were recruited by
researchers from the Barcelona Center of International Health
Research (CRESIB) under informed consent as part of routine
bacteriological surveillance of pneumonia. According to study
procedures, a conventional blood culture was performed for all
patients enrolled in the study at both sites, together with a
chest x-ray and a nasopharyngeal sample collection for viral
determination. Blood cultures were processed in the
microbiology laboratory of the Manhiça Health Research
Center (CISM) adjacent to the MDH and in the research
laboratory of the HER, which both operate under similar
standard operating procedures. In brief, one to 3 ml of whole
blood were inoculated in a pediatric blood culture bottle
(Pedibact®, Becton-Dickinson, Franklin Lanes, NJ, USA) and
incubated in an automated system (BACTEC® 9050, Becton-
Dickinson) for a minimum of 4 days. Positive blood cultures
were examined by Gram stain and subcultured on blood,
chocolate or MacConkey agar plates. Bacterial isolates were
identified by colony biochemical conventional methods, colony
morphologic analysis and growth requirements. Additionally,
four drops of blood were impregnated on properly identified
DBS, dried at room temperature and later inserted into
individual envelopes for shipment to University Hospital Sant
Joan de Déu in Barcelona.
DBS were also obtained as a control procedure from healthy
community children aged between 0-10 years, randomly
recruited from the Manhiça area, using the ongoing
demographic surveillance system and census run by CISM.
Parents or guardians of patients were also requested to
provide a written informed consent prior to inclusion in the
study. Children with respiratory illness requiring hospitalization
or medical treatment were excluded as controls. Children with
mild respiratory symptoms (e.g. cough, blocked nose or runny
nose) were not excluded. However, information about any
current symptoms was collected via a standardized
questionnaire. DBS from controls-children and DBS from case-
patients were shipped together to Barcelona.
Hib vaccine was introduced in Morocco in 2007, and is
currently included in its expanded Programme of Immunization
(EPI). Mozambique is an eligible country of the GAVI Alliance
and has been assisted in the areas of immunization and health
development since 2001. In April 2009 Hib vaccine was
introduced countrywide through the Mozambique’s EPI. No
pneumococcal conjugate vaccines were introduced in
Mozambique and Morocco during the study period. The burden
of Hib invasive disease in Mozambique is well documented and
high [16] while very scarce data on its incidence or impact are
available in Morocco [17].
Ethics Statement
The study protocols were both approved by the
corresponding National Ethics Committees (Comité Nacional
de Bioética em Saúde de Moçambique, CNBS, Maputo,
Mozambique; and Comité d’Éthique de la recherché
Biomédicale, (Départ N° 1252-16 Déc 2009) of the Faculty of
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medicine in Rabat, Morocco) together with the Hospital Clínic
of Barcelona Ethics Review Committee. Patients were recruited
by researchers from the Barcelona Center of International
Health Research (CRESIB) under informed consent. Parents or
guardians of patients were also requested to provide a written
informed consent prior to inclusion in the study.
Hib DNA detection by Real-Time PCR in DBS samples
Real-Time PCR for S. pneumoniae and Hib were performed
in all DBS (of patients and healthy controls). DNA extraction
was performed through the NucliSENS®
easyMAGTM(BioMérieux) system according to manufacturer’s
instructions and using a protocol that includes an external lysis
step.
Detection of S. pneumoniae was carried out by published
procedures that included the study of pneumolysin (ply) and
wzg genes (both had to be simultaneously positive to confirm
any case as a positive pneumococcal infection), and
subsequent capsular typing of S. pneumoniae DNA positive
samples [14,18]. Real-Time PCR of Hib was based on the
detection of bexA gene [19]. The Hib Real-Time PCR
performed with DBS was validated following the previously
described methodology [14]. Internal controls for monitoring
false negatives by PCR inhibitors were run for each sample to
monitor the overall assay performance and these consisted of
1 µl of TaqManRnase P control reagent (VIC) (Applied
Biosystem, Foster City, CA) that included human RNAse P
primers and probe. Negative results were defined as those with
cycle threshold (Ct) values above 40. Invalid results were
defined as those which showed no amplification of the target
gene and the internal control.
Statistical Analysis
Statistical analyses were performed using SPSS Statistics
for Windows software (version 19·0, IBM Corp.). Continuous
variables were compared using the t-test or the Mann-Whitney
U test, and categorical variables were compared using the Chi-
square test or Fisher exact test, as required. Confidence
Intervals (CI) were set at 95% and significance at a 2-sided p-
value of <0·05 for all statistical analyses.
Results
During the study period 329 patients fulfilling the inclusion
criteria with clinical diagnosis of pneumonia and 104 healthy
controls had DBS samples collected. Table 1 shows the
demographic characteristics of patients and controls included
in the study.
Blood culture samples were collected from all 329 patients,
17 of which (5·2%) were positive and 16 isolates (4·9%) were
considered contaminants. Among pathogenic bacteria,
Streptococcus pneumoniae was the most frequently isolated
pathogen (n=10; 3·1%) followed by Staphylococcus aureus
(n=2; 0·6%) and Salmonella spp (n=2; 0·6%). No Hib isolates
were detected in any of the two sites through the use of
conventional blood culture (Table 2).
Real-Time PCR was performed in 329 DBS samples for Hib
study and in 254 for S. pneumoniae. DNA extracts of first
series of 75 DBS consecutive samples of MDH were not
available for the study of S. pneumoniae, because samples
had been fully utilized for other molecular studies (data not
shown). Among these 75 cases, isolation of S. pneumoniae by
blood culture was detected in four patients and the rest were
negative. Detection of DNA of S. pneumoniae in DBS was
found in 23 (9%) of 254 patients studied (median age 16
months, range 4-93 months). 18 patients were attended in
MDH and 5 in HER; 3 additional patients with isolation of S.
pneumoniae by culture were not detected by PCR. It is
Table 1. Patients and control group characteristics.
Characteristics All MDH (%) HER (%)
Patients 329 231 98
Sex    
Male 174 112 (48.5) 62 (63.2)
Female 155 119 (51.5) 36 (36.8)
Age in months, median (range) 16 (0-119) 13 (0-119) 23 (0-78)
Age group    
<24 months 213 163 (70.6) 50 (51.0)
24-59 months 98 54 (23.4) 49 (49.0)
>59 months 14 14 (6)  
Control group 104 104  
Sex   *
Male 45 45 (43.3) *
Female 59 59 (56.7) *
Age in months, median (range) 37 (3-117) 37 (3-117) *
Age group    
<24 months 25 25 (24) *
24-59 months 63 63 (60.6) *
>59 months 16 16 (15.4) *
MDH: Manhiça District Hospital; HER: Hôpitald’enfants de Rabat. * No patients
available in HER
doi: 10.1371/journal.pone.0076970.t001
Table 2. Distribution of isolates by bacterial culture among
children of Mozambique and Morocco.
Pathogen Positive %
Streptococcus pneumoniae 10 3.1
Staphylococcus aureus 2 0.6
Salmonella spp  2 0.6
Pseudomonas spp  1 0.3
Burkholderia cepacia 1 0.3
Other BGN  1 0.3
Potential contaminants   
Coagulase negative Staphylococcus 12 3.6
Micrococcus luteus 1 0.3
Gram positive bacillus 3 0.9
Negative  296 89.9
Total pathogens detected 17* 5.1
*. Only considering clinically significant isolates
doi: 10.1371/journal.pone.0076970.t002
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noteworthy that 20 patients (87%) had a positive DBS result
with a negative blood culture for S. pneumoniae.
Hib DNA was detected by Real-Time PCR in 11 (3·3%) DBS
samples of 329 patients (median age 11 months, range 2-38
months). A negative result was obtained in 311 DBS samples
(94·5%) and an invalid result in 7 (2·1%). The proportion of
positive samples was higher in MDH (9 of 231; 3·9%) than in
HER (2 of 98; 2%) but without significant differences (p=0·19).
Among 11 DBS with positive detection of Hib DNA, 10 of them
were negative by blood culture and one yielded positive for S.
pneumoniae.
The addition of Real-Time PCR in DBS allowed a significant
increase in the detection capacity of microbiological diagnosis
of S. pneumoniae and Hib in the two health centers and in all
groups of age (Table 3). Indeed, with blood cultures, only ten
isolates of S. pneumoniae and none of Hib were detected
(3·0% positivity rate, IC95% 1·4-5·5%), while by adding Real-
Time PCR,30 S. pneumoniae and 11 Hib were identified;
meaning a net four-fold increase in positivity rate (n=41 cases,
12·4% positivity rate, IC95% 9·0-16·5%; P<0·002).
Among the 104 healthy community controls all DBS were
negative by Hib Real-Time PCR and 2 were positive for S.
pneumoniae. These corresponded to two children of 24 and 54
months of age both of whom presented mild respiratory
symptoms. Therefore Hib Real-Time PCR seemed more
specific (100%) than S. pneumoniae (98%) but without
significant differences (P=0·5). The lack of culture results for
the community controls however does not allow us to confirm
whether such patients were false or true positives.
Discussion
We had previously validated the use of DBS for diagnosis of
S. pneumoniae by using molecular methods [14]. In this study,
a Real-Time PCR for the analysis of Hib was developed and
adapted for use with DBS samples providing good sensitivity.
Dried blood spot (DBS) is a useful and easy-to-use method for
preserving and transporting blood samples which may have a
particular utility in developing countries, where microbiology
laboratories are rare and technical expertise is limited.
DBS blood collection provides a long-lasting and temperature-
stable method for storage of biological samples, and therefore
may be suitable for the diagnosis of bacterial or viral infections
by Real-Time PCR, as other authors have described
[12,14,20,21].
Although introduction of the Hib vaccine has resulted in a
reduction of the disease caused by Hib in Morocco [22], this
pathogen can still be detected as a cause of bacterial
pneumonia when we perform Real-Time PCR in DBS. The
results presented here, together with the reported burden of S.
pneumoniae and Hib [23] show that these pathogens continued
to cause more than 50% of microbiological confirmed severe
clinical pneumonia episodes. These data highlight the need to
support widespread implementation of the demonstrated highly
effective conjugate vaccines for these two pathogens. A
potential limitation in the Hib PCR applied in this study is that
bexA primers not only amplify Hib but also H. influenzae C
(Hic). However, as Hic is a very uncommon cause of invasive
disease in children we do not believe it could importantly affect
our results.
Table 3. Microbiological diagnosis of patients according to age group and geographical site.
Age group Patients studied  
Patients diagnosed by culture n (%;
95%CI)
Patients diagnosed only by real-time PCR n(%;
95%CI) Total patients diagnosed n (%; 95%CI)
Manhiça District Hospital (MDH)
S. pneumoniae
<24 months 109 3 (2.75; 0.6-8.1) 11 (10.1; 5.6-17.3) 14 (12.9; 7.6-20.5)
24-59 months 33 2 (6.1; 0.7-20.6) 5 (15.1; 6.1-31.4) 7 (21.2; 10.4-38.1)
>59 months 14 2 (14.3; 2.8-41.1) 2 (14.3; 2.8-41.1) 4 (28.6; 11.3-55)
Overall 156 7 (4.5; 2-9.1) 18 (11.5; 7.3-17.6) 25 (16; 11-22.6)
H. influenzae B
<24 months 163 0 6 (3.7; 1.5-8) 6 (3.7; 1.5-8)
24-59 months 54 0 3 (5.6; 1.3-15.7) 3 (5.6; 1.3-15.7)
>59 months 14 0 0 0
Overall 231 0 9 (3.9; 1.9-7.3) 9 (3.9; 1.9-7.3)
Hôpitald’enfants de Rabat (HER)
S. pneumoniae
<24 months 50 0 3 (6; 1.4-16.8) 3 (6; 1.4-16.8)
24-59 months 48 0 2 (4.5; 0.4-16) 2 (4.5; 0.4-16)
Overall 98 0 5 (5.1; 1.9-11.7) 5 (5.1; 1.9-11.7)
H. influenzae B
<24 months 50 0 2 (4; 0.3-14.2) 2 (4; 0.3-14.2)
24-59 months 44 0 0 0
>59 months 4 0 0 0
Overall 98 0 2 (2; 0.1-7.5) 2 (2; 0.1-7.5)
doi: 10.1371/journal.pone.0076970.t003
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Similarly to other previous evaluations, the performance of
classical microbiology to detect bacterial pathogens was poor,
detecting only a bacterial pathogen in a mere 5·2% of the
episodes. It is noteworthy that, Hib was not isolated in any of
the studied children by blood culture. Although some of these
cases may have been caused by non-bacterial pathogens or
conditions, the clinical manifestations and chest X-ray
characteristics of these patients were highly suggestive of a
high burden of bacterial-associated disease (data not shown).
The low positive rate of blood culture is similar to that reported
by other authors in pediatric populations, both for developed
and developing countries [24,25]. Notably, with the addition of
two specific Real-Time PCR for Hib and S. pneumoniae a four-
fold significant increase of the detection yield was achieved. If
we had included other molecular tests to improve detection of
pathogens such as Mycoplasma pneumoniae, S. aureus,
Salmonella or Klebsiella, among others, the increase of
etiological diagnosis may have been even more dramatic.
The lack of H. influenzae isolates detected using bacterial
cultures may be explained on account of Haemophilus spp
being fastidious organisms, difficult to grow in usual culture
conditions. Moreover, isolation rates can be further reduced
when samples are not adequately processed prior to their
arrival to the laboratory [26,27]. The use of antibiotics before
obtaining the sample, or the limited amount of blood that can
be obtained from young children are two other important
factors limiting the performance and decreasing the sensitivity
of traditional blood cultures, not only for the detection of Hib but
also for other pathogens. Considering that children aged less
than 2 years are the age group at a higher risk of Hib invasive
disease [28], a fact supported by our data (median age was
15·3 months) and that the amount of blood that can be
obtained from these children seldom exceeds 1-2mL it is
understandable that detection yields of blood culture are
necessarily low, when compared to the volumes that can be
used in older children or adults (5-10 ml). Microbiological
diagnosis by Real-Time PCR in only 1-2 drops of blood
impregnated in a paper spot is a really interesting contribution
to the available diagnostic tools that can bypass some of the
inherent problems of bacterial culture. Moreover, we can report
that the technique is highly specific, as data among healthy
control show and also proves to be sensitive, as shown by the
significant increase of microbiological diagnosis when PCR
was added.
However, three children with isolation of S. pneumoniae by
culture were not detected by PCR, probably due to the low
bacterial load and the minimum quantity of sample processed.
In this study we found a co-infection between S. pneumoniae
and Hib. Recently, van der Bergh et al. [29] have reported an
interesting study that shows S. pneumoniae colonization is
positively associated with the presence of H. influenzae. In
addition other authors have reported co-infection of S.
pneumoniae and Hib in children with otitis media [30]. However
little is known about co-infection of these pathogens in blood of
patients with pneumonia, probably due to the low sensitivity of
current microbiological methods.
In conclusion, in countries where health services are not
easily accessible, and where scarce epidemiological
surveillance systems exist for infectious diseases, molecular
testing applied to DBS can overcome the obstacles associated
with the collection, storage and shipment of samples,
facilitating the detection of S. pneumoniae and Hib. Thus,
improving the etiological surveillance of pneumonia in countries
with poor resources may have critical implications for
prevention and treatment policies. The promising results
published in the present study should encourage exploring the
detection of other pathogens with the same strategy.
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